Details

Autor(en) / Beteiligte

• Wang, Xi-Ying
• Zhang, Fen
• Zhang, Chi
• Zheng, Liang-Rong
• Yang, Jian
• De Lucia, Claudio
• Claudio De Lucia

Titel

The Biomarkers for Acute Myocardial Infarction and Heart Failure

Ist Teil von

• BioMed research international, 2020, Vol.2020, p.2018035-14

Ort / Verlag

United States: Hindawi

Erscheinungsjahr

2020

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk stratification, and prognosis and guides the management of patients with suspected cardiovascular diseases. There is a broad consensus that cardiac troponin and natriuretic peptides are the preferred biomarkers in clinical practice for the diagnosis of the acute coronary syndrome and heart failure, respectively, while the roles and possible clinical applications of several other potential biomarkers are still under study. This review mainly focuses on the recent studies of the roles and clinical applications of troponin and natriuretic peptides, which seem to be the best-validated markers in distinguishing and predicting the future cardiac events of patients with suspected cardiovascular diseases. Additionally, the review briefly discusses some of the large number of potential markers that may play a more prominent role in the future.